網(wǎng)站首頁(yè)>產(chǎn)品展示 > 衍生化/食品/藥品等標(biāo)準(zhǔn)品 > OLchem植物生長(zhǎng)素 > olchemim Phytohormone standards CYTOKININS

olchemim Phytohormone standards CYTOKININS

發(fā)布時(shí)間：2024-06-13

訪問次數(shù)：2391

公司地址：廣州市天河區(qū)天河北路僑林街47號(hào)中旅商務(wù)大廈東塔25E

產(chǎn)品價(jià)格：來(lái)電咨詢

產(chǎn)品詳情在線留言

The natural cytokinins are adenine derivatives bearing isoprenoid (zeatin, dihydrozeatin, isopentenyladenine) or aromatic (kinetin, benzyladenine, topolin) N⁶-side chain. Phenylureas (thidiazuron) and others are synthetic cytokinins. Cytokinins were recognized because of their ability to induce cell division in the presence of auxin but they are also involved in initiation of shoot primordia, in solute mobilization and cell senescence.

ADENINE (Ade) [6-aminopurine]

MW 135.13; crystalline; purity > 98% (HPLC)
R:22, S:26, 36; CAS:73-24-5; C₅H₅N₅

	001 0241	5	g
	001 0242	25	g
	001 0243	100	g
	001 0244	500	g

ADENINE HYDROCHLORIDE (Ade.HCl) [6-aminopurine hydrochloride]

MW 171.59; crystalline; purity > 98% (HPLC)
R:22, S:26, 36; CAS: 2922-28-3; C₅H₅N₅.HCl
water soluble

	001 3261	5	g
	001 3262	25	g
	001 3263	100	g

ADENINE HEMISULFATE (Ade.1/2H₂SO₄) [6-aminopurine hemisulfate]

MW 184.17; crystalline; purity > 98% (HPLC)
S:26, 36; CAS: 321-30-2; C₅H₅N₅.1/2H₂SO₄

	001 3271	5	g
	001 3272	25	g
	001 3273	100	g

ADENOSINE (Ado) [6-amino-9-β-D-ribofuranosylpurine]

MW 267.25; crystalline; purity > 98% (HPLC)
S:26, 36; CAS: 58-61-7; C₁₀H₁₃N₅O₄

	001 6301	5	g
	001 6302	25	g
	001 6303	100	g
	001 6304	500	g

N⁶-BENZYLADENINE (BA) [6 - benzylaminopurine]

MW 225.25; crystalline; purity > 98% (HPLC)
R:36/37/38, S:26, 36; CAS: 1214-39-7; C₁₂H₁₁N₅

	001 0221	1	g
	001 0222	5	g
	001 0223	25	g
	001 0224	100	g

N⁶-BENZYLADENINE HYDROCHLORIDE (BA.HCl) [6 - benzylaminopurine hydrochloride]

MW 261.71; crystalline; purity > 98% (HPLC)
R:36/37/38, S:26, 36; CAS: 162714-86-5; C₁₂H₁₁N₅.HCl
water soluble

	001 0181	250	mg
	001 0182	1	g
	001 0183	5	g

N⁶-BENZYLADENOSINE (BAR) [6-benzylamino-9-β-D-ribofuranosylpurine]

MW 357.37; crystalline; purity > 98% (HPLC)
S:26, 36; CAS: 4294-16-0; C₁₇H₁₉N₅O₄

	001 0551	100	mg
	001 0552	250	mg
	001 0553	1	g
	001 0554	5	g

N⁶-BENZYLADENINE-3-GLUCOSIDE (BA3G) [6-benzylamino-3-β-D-glucopyranosylpurine]

MW 387.40; crystalline; purity > 95% (HPLC )
S:26, 36; CAS: 56159-41-2; C₁₈H₂₁N₅O₅

	001 0581	1	mg
	001 0582	2	mg
	001 0583	5	mg

N⁶-BENZYLADENINE-7-GLUCOSIDE (BA7G) [6-benzylamino-7-β-D-glucopyranosylpurine]

MW 387.40; crystalline; purity > 95% (HPLC )
S:26, 36; CAS: 56159-42-3; C₁₈H₂₁N₅O₅

	001 0571	1	mg
	001 0572	2	mg
	001 0573	5	mg

N⁶-BENZYLADENINE-9-GLUCOSIDE (BA9G) [6-benzylamino-9-β-D-glucopyranosylpurine]

MW 387.40; crystalline; purity > 95% (HPLC )
R: 36/37/38, S: 26, 36; CAS: 4294-17-1; C₁₈H₂₁N₅O₅

	001 3281	1	mg
	001 3282	2	mg
	001 3283	5	mg

N⁶-BENZYL-9-(2-TETRAHYDROPYRANYL)ADENINE (BPA)

MW 309.37; crystalline; purity > 98% (HPLC )
R:22, S: 26,36; CAS: 2312-73-4; C₁₇H₁₉N₅O

	001 3291	100	mg
	001 3292	500	mg
	001 3293	1	g
	001 3294	5	g
	001 3295	25	g

N⁶ - BENZYLADENOSINE-5'-MONOPHOSPHATE SODIUM SALT (BAMP) [6-benzylamino-9-β-D-ribofuranosylpurine-5'-monophosphate disodium monohydrate]

MW 499.34; crystalline; purity > 95% (HPLC)
S:26, 36; CAS: 13484-66-7; C₁₇H₁₈N₅Na₂O₇P.H₂O

	001 5001	1	mg
	001 5002	2	mg
	001 5003	5	mg

N-(2-CHLORO-4-PYRIDYL)-N'-PHENYLUREA (CPPU,4-CPPU)

MW 247.69; crystalline; purity > 98% (HPLC)
R:36/37, S: 26, 36; CAS: 68157-60-8; C₁₀H₁₂ClN₃O

	001 0191	100	mg
	001 0192	250	mg
	001 0193	1	g

N⁶ - CYCLOPENTYLADENOSINE-5'-MONOPHOSPHATE SODIUM SALT (MP) [6-cyclopentylamino-9-β-D-ribofuranosylpurine-5'-monophosphate disodium monohydrate]

MW 459.31; CRYSTALLINE; purity > 97% (HPLC)
S:26, 36; CAS: 117778-38-8; C₁₅H₂₀N₅Na₂O₇P.H₂O

	001 6261	1	mg
	001 6262	2	mg
	001 6263	5	mg

DIHYDROZEATIN (DZ) [6-(4-hydroxy-3-methylbutylamino)purine]

MW 221.26; crystalline; purity > 99% (HPLC)
S:26, 36; CAS: 14894-18-9; C₁₀H₁₅N₅O

	001 0601	5	mg
	001 0602	10	mg
	001 0603	50	mg
	001 0604	250	mg
	001 0605	1	g

DIHYDROZEATIN HYDROCHLORIDE (DZ.HCl) [6-(4-hydroxy-3-methylbutylamino)purine hydrochloride]

MW 257.72; crystalline; purity > 98% (HPLC)
R:22, S:26, 36; CAS: 1402800-82-1; C₁₀H₁₅N₅O.HCl
water soluble

	001 0251	10	mg
	001 0252	50	mg
	001 0253	250	mg

DIHYDROZEATIN RIBOSIDE (DZR) [6-(4-hydroxy-3-methylbutylamino)-9-β-D-ribofuranosylpurine]

MW 353.38; crystalline; purity > 98% (HPLC)
S:26, 36; CAS: 22663-55-4; C₁₅H₂₃N₅O₅

	001 0611	5	mg
	001 0612	10	mg
	001 0613	50	mg
	001 0614	250	mg
	001 0615	1	g

DIHYDROZEATIN-7-GLUCOSIDE (DZ7G) [6-(4-hydroxy-3-methylbutylamino)-7-β-D-glucopyranosylpurine]

MW 383.41; crystalline; purity > 95% (HPLC)
S:26, 36; CAS: 91599-03-0; C₁₆H₂₅N₅O₆

	001 0621	1	mg
	001 0622	2	mg
	001 0623	5	mg

DIHYDROZEATIN-9-GLUCOSIDE (DZ9G) [6-(4-hydroxy-3-methylbutylamino)-9-β-D-glucopyranosylpurine]

MW 383.41; crystalline; purity > 95% (HPLC)
S:26, 36; CAS: 73263-99-7; C₁₆H₂₅N₅O₆

	001 0631	1	mg
	001 0632	2	mg
	001 0633	5	mg

DIHYDROZEATIN-O-GLUCOSIDE (DZOG) [6-(4-β-D-glucopyranosyloxy-3-methylbytylamino)purine]

MW 383.41; crystalline; purity > 95% (HPLC)
S:26, 36; CAS: 62512-96-3; C₁₆H₂₅N₅O₆

	001 0641	1	mg
	001 0642	2	mg
	001 0643	5	mg

DIHYDROZEATIN-O-GLUCOSIDE RIBOSIDE (DZROG) [6-(4-β-D-glucopyranosyloxy-3-methylbutyl)amino-9-β-D-purine ribofuranosyl]

MW 515.52; crystalline; purity > 95% (HPLC)
S:26, 36; CAS: 62512-95-2; C₂₁H₃₃N₅O₁₀

	001 0651	1	mg
	001 0652	2	mg
	001 0653	5	mg

DIHYDROZEATIN RIBOSIDE-5'-MONOPHOSPHATE SODIUM SALT (DZRMP) [6-(4-hydroxy-3-methylbutylamino)-9-β-D-ribofuranosyl purine-5'-monophosphate disodium monohydrate]

MW 495.34; crystalline; purity > 95% (HPLC)
S:26, 36; CAS: 31284-94-3; C₁₅H₂₂N₅Na₂O₈P.H₂O

	001 5011	1	mg
	001 5012	2	mg
	001 5013	5	mg

DIHYDROZEATIN-O-ACETYL (AcDZ) [6-(4-acetoxy-3-methylbutylamino)purine]

MW 263.30; crystalline; purity > 98% (HPLC)
S:26, 36; CAS: 126221-88-3; C₁₂H₁₇N₅O₂

	001 5021	5	mg
	001 5022	10	mg
	001 5023	50	mg

N⁶-(3-FLUOROBENZYL)ADENINE (mFBA) [6 - (3-fluorobenzylamino)purine]

MW 243.25; crystalline; purity > 98% (HPLC)
S:26, 36; CAS: 525608-36-0; C₁₂H₁₀FN₅

	001 5801	100	mg
	001 5802	500	mg
	001 5803	1	g

N⁶-(3-FLUOROBENZYL)ADENOSINE (mFBAR)[6-(3-fluorobenzylamino)-9-β-D-ribofuranosylpurine]

MW 375.36; crystalline; purity > 98% (HPLC)
S:26, 36; CAS: 29204-64-6; C₁₇H₁₈FN₅O₄

	001 5811	100	mg
	001 5812	500	mg
	001 5813	1	g
	001 5814	5	g

HYPOXANTHINE (Hyp) [6-hydroxypurine]

MW 136.11; crystalline; purity > 98% ( HPLC )
S:26, 36; CAS: 68-94-0; C₅H₄N₄O

	001 5941	5	g
	001 5942	25	g
	001 5943	100	g

N⁶-ISOPENTENYLADENINE (iP) [6-(3,3-dimethylallylamino)purine]

MW 203.25; crystalline; purity > 99% (HPLC)
S:26, 36; CAS: 2365-40-4; C₁₀H₁₃N₅

	001 0161	1	g
	001 0162	5	g
	001 0163	10	g
	001 0164	25	g

N⁶-ISOPENTENYLADENINE HYDROCHLORIDE (iP.HCl) [6-(3,3-dimethylallylamino)purine hydrochloride]

MW 239.71; crystalline; purity > 98% (HPLC)
R:22, S:26, 36; CAS: 177966-67-5; C₁₀H₁₃N₅.HCl
water soluble

	001 5031	1	g
	001 5032	5	g
	001 5033	10	g

N⁶-ISOPENTENYLADENOSINE (iPR) [6-(3,3-dimethylallylamino)-9-β-D-ribofuranosylpurine]

MW 335.37; crystalline; purity > 99% (HPLC)
S:26, 36; CAS: 7724-76-7; C₁₅H₂₁N₅O₄

	001 0171	100	mg
	001 0172	250	mg
	001 0173	1	g

2-BENZYLTHIO-N⁶-ISOPENTENYLADENINE (2BSiP)[2-benzylthio-6-(3,3-dimethylallylamino)purine]

MW 325.44; crystalline; purity > 98% (HPLC)
S:26, 36; CAS: 52172-11-9; C₁₇H₁₉N₅S

	001 5241	5	mg
	001 5242	10	mg
	001 5243	50	mg

2-METHYLTHIO-N⁶-ISOPENTENYLADENINE (2MeSiP) [2-methylthio-6-(3,3-dimethylallylamino)purine]

MW 249.34; crystalline; purity > 98% (HPLC)
S:23, 36; CAS: 20758-33-2; C₁₁H₁₅N₅S

	001 5071	1	mg
	001 5072	2	mg
	001 5073	5	mg

2-METHYLTHIO-N⁶-ISOPENTENYLADENOSINE (2MeSiPR) [2-methylthio-6-(3,3-dimethylallylamino)-9-β-D-ribofuranosylpurine]

MW 381.46; CRYSTALLINE; purity > 95% (HPLC)
S:26, 36; CAS: 20859-00-1; C₁₆H₂₃N₅O₄S

	001 5061	1	mg
	001 5062	2	mg
	001 5063	5	mg

2-MERCAPTO-N⁶-ISOPENTENYLADENINE (2SiP) [2-mercapto-6-(3,3-dimethylallylamino)purine]

MW 235.31; crystalline; purity > 95% (HPLC)
S:26, 36; CAS: 52172-12-0; C₁₀H₁₃N₅S

	001 5081	1	mg
	001 5082	2	mg
	001 5083	5	mg

N⁶-ISOPENTENYLADENINE-3-GLUCURONIDE (iP3GN)

MW 379.38; CRYSTALLINE; purity > 97% (HPLC)
S:26, 36; CAS: 147663-48-7; C₁₆H₂₁N₅O₆

	001 5981	5	mg
	001 5982	25	mg
	001 5983	50	mg

N⁶-ISOPENTENYLADENINE-3-GLUCURONIDE amide (iP3GNA)

MW 378.39; CRYSTALLINE; purity > 98% (HPLC)
S:26, 36; CAS: NONE; C₁₆H₂₂N₆O₅

	001 5991	5	mg
	001 5992	25	mg
	001 5993	50	mg

N⁶-ISOPENTENYLADENOSINE-5'-MONOPHOSPHATE SODIUM SALT (iPMP) [6-(3,3-dimethylallylamino)-9-b-D-ribofuranosylpurine-5'-monophosphate disodium monohydrate]

MW 477.33; crystalline; purity > 95% (HPLC)
S:26, 36; CAS: 20268-93-3; C₁₅H₂₀N₅Na₂O₇P.H₂O

	001 5041	1	mg
	001 5042	2	mg
	001 5043	5	mg

N⁶-ISOPENTENYLADENINE-7-GLUCOSIDE (iP7G) [6-(3,3-dimethylallylamino)-7-β-D-glucopyranosylpurine]

MW 365.39; crystalline; purity > 95% (HPLC)
S:26, 36; CAS: 59384-58-6; C₁₆H₂₃N₅O₅

	001 5051	1	mg
	001 5052	2	mg
	001 5053	5	mg

N⁶-ISOPENTENYLADENINE-9-GLUCOSIDE (iP9G) [6-(3,3-dimethylallylamino)-9-β-D-glucopyranosylpurine]

MW 365.39; crystalline; purity > 95% (HPLC)
S:26, 36; CAS: 83087-94-9; C₁₆H₂₃N₅O₅

	001 0231	1	mg
	001 0232	2	mg
	001 0233	5	mg

KINETIN (K) [6-furfurylaminopurine]

MW 215.22; crystalline; purity > 99% (HPLC)
S:26, 36; CAS: 525-79-1; C₁₀H₉N₅O

	001 0341	250	mg
	001 0342	1	g
	001 0343	5	g
	001 0344	25	g

KINETIN HYDROCHLORIDE(K.HCl) [6-furfurylaminopurine hydrochloride]

MW 251.68; crystalline; purity > 98% (HPLC)
R:22, S:26, 36; CAS: 177966-68-6; C₁₀H₉N₅O.HCl
water soluble

	001 0261	100	mg
	001 0262	500	mg
	001 0263	1	g

KINETIN RIBOSIDE (KR) [6 - furfurylamino-9-b-D-ribofuranosylpurine]

MW 347.33; crystalline; purity > 99% (HPLC)
S:26, 36; CAS: 4338-47-0; C₁₅H₁₇N₅O₅

	001 0351	100	mg
	001 0352	250	mg
	001 0353	1	g
	001 0354	5	g

KINETIN-3-GLUCOSIDE (αK3G) [6-furfurylamino-3-α-D-glucopyranosylpurine]

MW 377.36; crystalline; purity > 95% (HPLC )
S:26, 36; CAS: 900786-14-3; C₁₆H₁₉N₅O₆

	001 5771	1	mg
	001 5772	2	mg
	001 5773	5	mg

KINETIN-9-GLUCOSIDE (K9G) [6-furfurylamino-9-β-D-glucopyranosylpurine]

MW 377.36; crystalline; purity > 95% (HPLC )
S:26, 36; CAS: 98177-43-6; C₁₆H₁₉N₅O₆

	001 0441	1	mg
	001 0442	2	mg
	001 0443	5	mg

KINETIN RIBOSIDE-5'-MONOPHOSPHATE SODIUM SALT (KMP) [6-furfurylamino-9-β-D-ribofuranosylpurine-5'-monophosphate disodium monohydrate]

MW 489.30; crystalline; purity > 95% (HPLC)
S:26, 36; CAS: 13484-67-8; C₁₅H₁₆N₅Na₂O₈P.H₂O

	001 5091	1	mg
	001 5092	2	mg
	001 5093	5	mg

PHENYLADENINE [6-phenylaminopurine, 6-anilinopurine]

MW 211.23; crystalline; purity > 95% (HPLC)
R:36/37/38; S:26, 36; CAS:1210-66-8; C₁₁H₉N₅

	001 6971	100	mg
	001 6972	500	mg
	001 6973	1	g
		MSDS

THIDIAZURON (TDZ) [N-phenyl-N'-(1,2,3-thiadiazol-5-yl)urea]

MW 220.25; crystalline; purity > 98% (HPLC )
R:36/37/38, S:22, 26, 36; CAS: 51707-55-2; C₉H₈N₄OS

	001 3161	5	mg
	001 3162	25	mg
	001 3163	250	mg
	001 3164	1	g
	001 3165	5	g

meta-TOPOLIN (mT) [6-(3-hydroxybenzylamino)purine]

MW 241.25; crystalline; purity >99% (HPLC)
S:26, 36; CAS: 75737-38-1; C₁₂H₁₁N₅O

	001 0101	100	mg
	001 0102	500	mg
	001 0103	1	g
	001 0104	5	g
	001 0105	25	g

meta-TOPOLIN RIBOSIDE (mTR) [6-(3-hydroxybenzylamino)-9-b-D-ribofuranosylpurine]

MW 373.37; crystalline;purity >99% (HPLC)
S:26, 36; CAS: 110505-76-5; C₁₇H₁₉N₅O₅

	001 0111	100	mg
	001 0112	500	mg
	001 0113	1	g

meta-TOPOLIN-9-GLUCOSIDE (mT9G) [6-(3-hydroxybenzylamino)-9-β-D-glucopyranosylpurine]

MW 403.40; crystalline; purity >95% (HPLC)
S:26, 36; CAS: 179528-30-4; C₁₈H₂₁N₅O₆

	001 0141	1	mg
	001 0142	2	mg
	001 0143	5	mg

meta-TOPOLIN RIBOSIDE-5'-MONOPHOSPHATE SODIUM SALT (mTMP) [6-(3-hydroxybenzylamino)-9-β-D-ribofuranosylpurine-5'-monophosphate disodium monohydrate]

MW 515.34; crystalline; purity > 95% (HPLC)
S:26, 36; CAS: 946853-27-6; C₁₇H₁₈N₅Na₂O₈P.H₂O

	001 6841	1	mg
	001 6842	2	mg
	001 6843	5	mg

ortho-TOPOLIN (oT) [6-(2-hydroxybenzylamino)purine]

MW 241.25; crystalline; purity > 99% (HPLC)
S:26, 36; CAS: 20366-83-0; C₁₂H₁₁N₅O

	001 0121	100	mg
	001 0122	500	mg
	001 0123	1	g

ortho-TOPOLIN RIBOSIDE (oTR)[6-(2-hydroxybenzylamino)-9-b-D-ribofuranosylpurine]

MW 373.37; crystalline; purity > 99% (HPLC)
S:26, 36; CAS: 50868-58-1; C₁₇H₁₉N₅O₅

	001 0131	100	mg
	001 0132	500	mg
	001 0133	1	g

ortho-TOPOLIN-9-GLUCOSIDE (oT9G) [6-(2-hydroxybenzylamino)-9-β-D-glucopyranosylpurine]

MW 403.40; crystalline; purity >95% (HPLC)
S:26, 36; CAS: 160299-96-7; C₁₈H₂₁N₅O₆

	001 0151	1	mg
	001 0152	2	mg
	001 0153	5	mg

ortho-TOPOLIN RIBOSIDE-5'-MONOPHOSPHATE SODIUM SALT (oTMP) [6-(2-hydroxybenzylamino)-9-β-D-ribofuranosylpurine-5'-monophosphate disodium monohydrate]

MW 515.34; crystalline; purity > 95% (HPLC)
S:26, 36; CAS: 1242061-01-3; C₁₇H₁₈N₅Na₂O₈P.H₂O

	001 6831	1	mg
	001 6832	2	mg
	001 6833	5	mg

para-TOPOLIN (pT) [6-(4-hydroxybenzylamino)purine]

MW 241.25; crystalline; purity > 99% (HPLC)
S:26, 36; CAS: 80054-30-4; C₁₂H₁₁N₅O

	001 0451	100	mg
	001 0452	500	mg
	001 0453	1	g

para-TOPOLIN RIBOSIDE (pTR) [6-(4-hydroxybenzylamino)-9-b-D-ribofuranosylpurine]

MW 373.37; crystalline; purity > 99% (HPLC)
S:26, 36; CAS: 23666-24-2; C₁₇H₁₉N₅O₅

	001 0461	100	mg
	001 0462	500	mg
	001 0463	1	g

para-TOPOLIN-9-GLUCOSIDE (pT9G) [6-(4-hydroxybenzylamino)-9-β-D-glucopyranosylpurine]

MW 403.40; crystalline; purity >95% (HPLC)
S:26, 36; CAS: 1046433-04-8; C₁₈H₂₁N₅O₆

	001 0401	1	mg
	001 0402	2	mg
	001 0403	5	mg

para-TOPOLIN RIBOSIDE-5'-MONOPHOSPHATE SODIUM SALT (pTMP) [6-(3-hydroxybenzylamino)-9-β-D-ribofuranosylpurine-5'-monophosphate disodium monohydrate]

MW 515.34; crystalline; purity > 95% (HPLC)
S:26, 36; CAS: 1402800-77-4; C₁₇H₁₈N₅Na₂O₈P.H₂O

	001 6851	1	mg
	001 6852	2	mg
	001 6853	5	mg

ortho-METHOXYTOPOLIN (MeoT) [6-(2-methoxybenzylamino)purine]

MW 255.28; crystalline; purity > 99% (HPLC)
S:26, 36; CAS: 75737-41-6; C₁₃H₁₃N₅O

	001 0491	100	mg
	001 0492	500	mg
	001 0493	1	g

ortho-METHOXYTOPOLIN RIBOSIDE (MeoTR) [6-(2-methoxybenzylamino)-9-β-D-ribofuranosylpurine]

MW 387.40; crystalline; purity > 99% (HPLC)
S:26, 36; CAS: 23660-98-2; C₁₈H₂₁N₅O₅

	001 0501	100	mg
	001 0502	500	mg
	001 0503	1	g

ortho-METHOXYTOPOLIN-9-GLUCOSIDE (MeoT9G) [6-(2-methoxybenzylamino)-9-β-D-glucopyranosylpurine]

MW 417.43; crystalline; purity > 95% (HPLC)
S:26, 36; CAS: 1226978-27-7; C₁₉H₂₃N₅O₆

	001 5861	1	mg
	001 5862	2	mg
	001 5863	5	mg

meta-METHOXYTOPOLIN (MemT) [6-(3-methoxybenzylamino)purine]

MW 255.28; crystalline; purity > 99% (HPLC)
S:26, 36; CAS: 75737-39-2; C₁₃H₁₃N₅O

	001 0511	100	mg
	001 0512	500	mg
	001 0513	1	g

meta-METHOXYTOPOLIN RIBOSIDE (MemTR) [6-(3-methoxybenzylamino)-9-β-D-ribofuranosylpurine]

MW 387.40; crystalline; purity > 99% (HPLC)
S:26, 36; CAS: 101565-95-1; C₁₈H₂₁N₅O₅

	001 0531	100	mg
	001 0532	500	mg
	001 0533	1	g

meta-METHOXYTOPOLIN-9-GLUCOSIDE (MeoT9G) [6-(3-methoxybenzylamino)-9-β-D-glucopyranosylpurine]

MW 417.43; crystallinE; purity > 95% (HPLC)
S:26, 36; CAS: 1226978-27-7; C₁₉H₂₃N₅O₆

	001 5871	1	mg
	001 5872	2	mg
	001 5873	5	mg

para-METHOXYTOPOLIN-9-GLUCOSIDE (MeoT9G) [6-(4-methoxybenzylamino)-9-β-D-glucopyranosylpurine]

MW 417.43; crystalline; purity > 95% (HPLC)
S:26, 36; CAS: NONE; C₁₉H₂₃N₅O₆

	001 5881	1	mg
	001 5882	2	mg
	001 5883	5	mg

trans-ZEATIN (tZ) [6-((E)-4-hydroxy-3-methylbut-2-enylamino)purine]

MW 219.25; crystalline; purity > 99% (HPLC); white crystalls; cis-isomer < 0.05%
S:26, 36; CAS: 1637-39-4; C₁₀H₁₃N₅O

	001 0301	5	mg
	001 0302	10	mg
	001 0303	100	mg
	001 0304	1	g

trans-ZEATIN HYDROCHLORIDE (tZ.HCl) [6-((E)-4-hydroxy-3-methylbut-2-enylamino)purine hydrochloride]

MW 255.71; crystalline; purity > 97% (HPLC)
R:22, S:36; CAS: 6025-81-6; C₁₀H₁₃N₅O.HCl
water soluble

	001 5101	100	mg
	001 5102	250	mg
	001 5103	1	g

trans-ZEATIN RIBOSIDE (tZR) [6-((E)-4-hydroxy-3-methylbut-2-enylamino)-9-β-D-ribofuranosylpurine]

MW 351.37; crystalline; purity > 99% (HPLC); white crystalls; cis-isomer < 0.05%
S:26, 36; CAS: 6025-53-2; C₁₅H₂₁N₅O₅

	001 0311	5	mg
	001 0312	10	mg
	001 0313	100	mg
	001 0314	1	g

ZEATIN mixed isomers (E/Z) equal mixture of cis- and trans- isomers [6-(4-hydroxy-3-methylbut-2-enylamino)purine]

MW 219.25; crystalline; purity > 98% (HPLC)
S:26, 36; CAS: 13114-27-7; C₁₀H₁₃N₅O

	001 3171	5	mg
	001 3172	10	mg
	001 3173	100	mg
	001 3174	1	g

ZEATIN RIBOSIDE mixed isomers (E/Z) equal mixture of cis- and trans- isomers [6-(4-hydroxy-3-methylbut-2-enylamino)-9-β-D-ribofuranosylpurine]

MW 351.37; crystalline; purity > 98% (HPLC)
S:26, 36; CAS: 28542-78-1; C₁₅H₂₁N₅O₅

	001 3181	5	mg
	001 3182	10	mg
	001 3183	100	mg
	001 3184	1	g

trans-ZEATIN-7-GLUCOSIDE (tZ7G) [6-((E)-4-hydroxy-3-methylbut-2-enylamino)-7-b-D-glucopyranosylpurine]

MW 381.39; crystalline; purity > 95% (HPLC)
S:26, 36; CAS: 38165-56-9; C₁₆H₂₃N₅O₆

	001 5111	1	mg
	001 5112	2	mg
	001 5113	5	mg

trans-ZEATIN-9-GLUCOSIDE (tZ9G) [6-((E)-4-hydroxy-3-methylbut-2-enylamino)-9-β-D-glucopyranosylpurine]

MW 381.39; crystalline; purity > 95% (HPLC)
S:26, 36; CAS: 51255-96-0; C₁₆H₂₃N₅O₆

	001 0471	1	mg
	001 0472	2	mg
	001 0473	5	mg

trans-ZEATIN-9-GLUCURONIDE (tZ9GN)

MW 395.38; crystalline; purity > 95% (HPLC)
S:26, 36; CAS: NONE; C₁₆H₂₁N₅O₇

	001 5961	5	mg
	001 5962	10	mg
	001 5963	50	mg

trans-ZEATIN-O-GLUCOSIDE (tZOG) [6-((E)-4-β-D-glucopyranosyloxy-3-methylbut-2-enylamino)purine]

MW 381.39; crystalline; purity > 95% (HPLC)
S:26, 36; CAS: 56329-06-7; C₁₆H₂₃N₅O₆

	001 5121	1	mg
	001 5122	2	mg
	001 5123	5	mg

trans-ZEATIN-O-GLUCURONIDE (tZOGN)

MW 395.38; CRYSTALLINE; purity > 95% (HPLC)
S:26, 36; CAS: 147663-51-2; C₁₆H₂₁N₅O₇

	001 5971	5	mg
	001 5972	10	mg
	001 5973	50	mg

trans-ZEATIN-O-GLUCOSIDE RIBOSIDE (tZROG) [6-((E)-4-β-D-glucopyranosyloxy-3-methylbut-2-enylamino)-9-β-D-ribofuranosylpurine]

MW 513.51; crystalline; purity > 95% (HPLC)
S:26, 36; CAS: 62512-97-4; C₂₁H₃₁N₅O₁₀

	001 5131	1	mg
	001 5132	2	mg
	001 5133	5	mg

trans-ZEATIN RIBOSIDE-5'-MONOPHOSPHATE SODIUM SALT (tZMP) [6-((E)-4-hydroxy-3-methylbut-2-enylamino)-9-β-D-ribofuranosylpurine-5'-monophosphate disodium monohydrate]

MW 499.33; crystalline; purity > 95% (HPLC)
S:26, 36; CAS: 25615-16-1; C₁₅H₂₀N₅Na₂O₈P.H₂O

	001 5141	1	mg
	001 5142	2	mg
	001 5143	5	mg

trans-ZEATIN-9-GLUCOSIDE-O-GLUCOSIDE (tZ9GOG) [6-((E)-4-β-D-glucopyranosyloxy-3-methylbut-2-enylamino)-9-β-D-glucopyranosylpurine]

MW 543.64; crystalline; purity > 95% (HPLC)
S:26, 36; CAS: 115921-05-6; C₂₂H₃₃N₅O₁₁

	001 5501	1	mg
	001 5502	2	mg
	001 5503	5	mg

trans-ZEATIN-O-ACETYL (ActZ) [6-((E)-4-acetoxy-3-methylbut-2-enylamino)purine]

MW 261.29; crystalline; purity > 98% (HPLC)
S:26, 36; CAS: 6025-82-7; C₁₂H₁₅N₅O₂

	001 5151	1	mg
	001 5152	2	mg
	001 5153	5	mg

2-CHLORO-trans-ZEATIN (2CltZ) [2-chloro-6-((E)-4-hydroxy-3-methylbut-2-enylamino)purine]

MW 253.69; crystalline; purity > 98% (HPLC)
S:26, 36; CAS: 29736-30-9; C₁₀H₁₂ClN₅O

	001 5161	5	mg
	001 5162	10	mg
	001 5163	50	mg

2-METHYLTHIO-trans-ZEATIN (2MeStZ) [2-methylthio-6-((E)-4-hydroxy-3-methylbut-2-enylamino)purine]

MW 265.34; crystalline; purity > 95% (HPLC)
S:26, 36; CAS: 29736-33-2; C₁₁H₁₅N₅OS

	001 5171	1	mg
	001 5172	2	mg
	001 5173	5	mg

2-METHYLTHIO-trans-ZEATIN RIBOSIDE (2MeStZR) [2-methylthio-6-((E)-4-hydroxy-3-methylbut-2-enylamino)-9-b-D-ribofuranosylpurine]

MW 397.46; crystalline; purity > 95% (HPLC)
S:26, 36; CAS: 53274-45-6; C₁₆H₂₃N₅O₅S

	001 5181	1	mg
	001 5182	2	mg
	001 5183	5	mg

cis-ZEATIN (cZ) [6-((Z)-4-hydroxy-3-methylbut-2-enylamino)purine]

MW 219.25; crystalline; purity > 99% (HPLC)
S:26, 36; CAS: 32771-64-5; C₁₀H₁₃N₅O

	001 0321	5	mg
	001 0322	10	mg
	001 0323	50	mg

cis-ZEATIN RIBOSIDE (cZR) [6-((Z)-4-hydroxy-3-methylbut-2-enylamino)-9-b-D-ribofuranosylpurine]

MW 351.37; crystalline; purity > 99% (HPLC)
S:26, 36; CAS: 15896-46-5; C₁₅H₂₁N₅O₅

	001 0331	5	mg
	001 0332	10	mg
	001 0333	50	mg

cis-ZEATIN-9-GLUCOSIDE (cZ9G) [6-((Z)-4-hydroxy-3-methylbut-2-enylamino)-9-β-D-glucopyranosylpurine]

MW 381.39; crystalline; purity > 95% (HPLC)
S:26, 36; CAS: 169565-72-4; C₁₆H₂₃N₅O₆

	001 2891	1	mg
	001 2892	2	mg
	001 2893	5	mg

cis-ZEATIN-O-GLUCOSIDE (cZOG) [6-((Z)-4-β-D-glucopyranosyloxy-3-methylbut-2-enylamino)purine]

MW 381.39; crystalline; purity > 95% (HPLC)
S:26, 36; CAS: 71866-93-8; C₁₆H₂₃N₅O₆

	001 3391	1	mg
	001 3392	2	mg
	001 3393	5	mg

cis-ZEATIN-O-GLUCOSIDE RIBOSIDE (cZROG) [6-((Z)-4-β-D-glucopyranosyloxy-3-methylbut-2-enylamino)-9-β-D-ribofuranosylpurine]

MW 513.51; crystalline; purity > 95% (HPLC)
S:26, 36; CAS: 125225-72-1; C₂₁H₃₁N₅O₁₀

	001 3251	1	mg
	001 3252	2	mg
	001 3253	5	mg

cis-ZEATIN RIBOSIDE-5'-MONOPHOSPHATE SODIUM SALT (cZMP) [6-((Z)-4-hydroxy-3-methylbut-2-enylamino)-9-β-D-ribofuranosylpurine-5'-monophosphate disodium monohydrate]

MW 499.33; crystalline; purity > 95% (HPLC)
S:26, 36; CAS: 125225-71-0; C₁₅H₂₀N₅Na₂O₈P.H₂O

	001 0591	1	mg
	001 0592	2	mg
	001 0593	5	mg

2-METHYLTHIO-cis-ZEATIN (2MeScZ) [2-methylthio-6-((Z)-4-hydroxy-3-methylbut-2-enylamino)purine]

MW 265.34; crystalline; purity > 95% (HPLC)
S:26, 36; CAS: 52020-11-8; C₁₁H₁₅N₅OS

	001 0541	1	mg
	001 0542	2	mg
	001 0543	5	mg

2-METHYLTHIO-cis-ZEATIN RIBOSIDE (2MeScZR) [2-methylthio-6-((Z)-4-hydroxy-3-methylbut-2-enylamino)-9-β-D-ribofuranosylpurine]

MW 397.46; crystalline; purity > 95% (HPLC)
S:26, 36; CAS: 52049-48-6; C₁₆H₂₃N₅O₅S

	001 0561	1	mg
	001 0562	2	mg
	001 0563	5	mg

上一條：E589400 C125702TRC C175685 C155360 O148490 Z270500 P206500

下一條：olchemim Phytohormone standards OPTICALLY-ACTIVE

欧美一区二区三区在线视频免费看,一区二区无毒不卡,91在线麻豆观看视频,日韩欧美aⅴ综合网站发布,久久久久国产精品精品,色婷婷色综合一区二区,亚洲欧美日本另类一区,亚洲视频图片qs在线,欧美日韩一区涩色

olchemim Phytohormone standards CYTOKININS

留言框

產(chǎn)品：

您的單位：

您的姓名：

聯(lián)系電話：

常用郵箱：

省份：

詳細(xì)地址：

補(bǔ)充說(shuō)明：

驗(yàn)證碼：